Coronavirus: Commission concludes talks to secure future coronavirus vaccine for Europeans
The European Commission has concluded exploratory talks with a pharmaceutical company to purchase a potential vaccine against COVID-19. The envisaged contract with Sanofi-GSK* would provide for an option for all EU Member States to purchase the vaccine. It is envisaged that, once a vaccine has proven to be safe and effective against COVID-19, the Commission would have a contractual framework in place for the purchase of 300 million doses, on behalf of all EU Member States. The Commission continues intensive discussions with other vaccine manufacturers.
President von der Leyen recently said:
“The European Commission does all in its power to ensure that Europeans have rapid access to a vaccine that is safe and protects them from coronavirus. Today's step with Sanofi-GSK is a first important cornerstone of a much broader European Vaccines Strategy. More will follow soon. We are in advanced discussions with several other companies. While we do not know today which vaccine will work best in the end, Europe is investing in a diversified portfolio of promising vaccines, based on various types of technologies. This increases our chances to obtain rapidly an effective remedy against the virus. A vaccine would be a truly global good. We are committed to help secure access also for more vulnerable countries to find their way out of this crisis.”
Stella Kyriakides, Commissioner for Health and Food Safety, recently said:
“A safe and effective COVID-19 vaccine is the surest exit strategy from the crisis. For that reason, we have been negotiating a united EU approach to secure doses of promising vaccine candidates in recent weeks. Today's announcement of the conclusion of exploratory talks with Sanofi-GSK is the first important step in this direction, to provide equal access to the vaccine for our citizens.”
The exploratory talks concluded recently (31 July 2020) are intended to result in an Advance Purchase Agreement to be financed with the Emergency Support Instrument, which has funds dedicated to the creation of a portfolio of potential vaccines with different profiles and produced by different companies.
The European Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe.
This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery.
The Commission is also ready to explore with international partners if a significant number of countries would agree to pool resources for jointly reserving future vaccines from companies for themselves as well as for low and middle-income countries at the same time. The high-income countries could act as an inclusive international buyers' group, thus accelerating the development of safe and effective vaccines and maximise access to them for all who need it across the world.
Latest News from
COVID-19: Member states need to harmonise health assessments and measures18/09/2020 16:33:00
Common definitions, health criteria and methodologies are key to effectively fighting the ongoing pandemic and its economic consequences in the EU, MEPs say.
Poland: Council has to “finally act” to protect minorities and the rule of law18/09/2020 15:25:00
Disrespect for judicial independence and the rights of LGBTI persons point to “overwhelming evidence” of breaches of EU values, Parliament says.
COVID-19 vaccines: Public hearing in European Parliament18/09/2020 14:33:00
Addressing the challenges linked to securing access to safe COVID-19 vaccines will be the main topic of an online hearing on 22 September from 09.00-12.00 in the European Parliament.
Parliament requests more support for regions to make energy transition a success18/09/2020 13:25:00
MEPs are ready to start negotiations with the Council on setting up the Just Transition Fund to mitigate the social impact of greening the economy.
European Green Deal Call: €1 billion investment to boost the green and digital transition18/09/2020 12:38:00
The European Commission yesterday decided to launch a €1 billion call for research and innovation projects that respond to the climate crisis and help protect Europe's unique ecosystems and biodiversity.
EU arms exports: need for more control and transparency18/09/2020 11:33:00
EU citizens have to be better informed about their governments’ strategic choices on an issue that directly affects their security, warn MEPs.
COVID-19: EU must step up efforts to tackle medicine shortages18/09/2020 10:38:00
Parliament calls for the EU to be more self-sufficient when it comes to medicines and medical equipment so that affordable treatments are available at any time.
Parliament says shipping industry must contribute to climate neutrality18/09/2020 09:25:00
To decarbonise maritime transport, Parliament voted to include CO2 emissions from the sector in the EU Emissions Trading System.
Vote on Own Resources: MEPs clear way for COVID-19 recovery plan17/09/2020 16:33:00
MEPs accelerate the procedure that will enable the EU to borrow €750 billion for the “Next Generation EU” recovery plan.